Michael O'Rourke, CEO of Re-Vana Therapeutics, presents online at the Ophthalmology Futures Forums on Wednesday, September 30th, 2020. https://youtu.be/iUBtmg7jCWo
Welcome to BusinessCloud’s Northern Ireland Tech 50 ranking for 2020. Cemetery software firm PlotBox tops our inaugural ranking of Northern Ireland’s most innovative technology companies. See Full Article at BusinessCloud >>
See the entire Opthamology Future Forum Advisory Board at: https://www.ophthalmology-futures.com/about-us/advisory-board/
Belfast, Northern Ireland – June 2, 2020 – Re-Vana Therapeutics Ltd, a privately-held specialty therapeutic and drug delivery company developing sustained-release therapeutics for significant sight-threatening ocular diseases, today announced that it has closed $3.25...
… The late-morning session, titled “New Horizons in Drug Delivery,” will focus exciting innovations in drug delivery systems, with moderators Michael Robinson, MD, vice president and Therapeutic Area head, Allergan; and James C. Tsai, MD, MBA, National Eye Health...
Queen’s University Belfast has came top of University rankings, beating both Oxford and Cambridge, to be recognised as the most entrepreneurial University in the UK, according to a new report published by Octopus Ventures.
Re-Vana has developed a novel disruptive photocrosslinked proprietary biodegradable sustained release drug delivery implant, EyeLief. The implant will provide significant clinical benefits over current monthly intravitreal injections. Following injection into the eye,...
Michael O’Rourke CEO presents Re-Vana at the OIS ASRS in Chicago 25th July 2019 (5 mins) Presentation
Michael O'Rourke CEO presents Re-Vana at the OIS ASRS in Chicago 25th July 2019 (5 mins) Presentation
Michael O’Rourke CEO interviewed on his insights into drug delivery trends and what makes Re-Vana different! (11 mins)
Michael O'Rourke CEO interviewed on his insights into drug delivery trends and what makes Re-Vana different! (11 mins)
Expert Panel review on ophthalmic drug delivery experts - 21 mins (Re-Vana discussed at at 5 min 15 secs and 6 mins 10 secs)
<a href="//www.revanatx.com/wp-content/uploads/2019/06/SAB_PR_June2019_Final.pdf" target="_blank" rel="noopener noreferrer">Re-Vana Therapeutics Names Renowned International Experts to Inaugural Scientific Advisory Board</a>
Michael O’Rourke CEO to present at the Ophthalmic Futures Forum – Vienna September 19th & 20th 2018 https://www.ophthalmology-futures.com/retina-forum-2018-programme/